Researcher
Annelies Verbiest
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Oct 2016 → 30 Sep 2020
Projects
1 - 1 of 1
- Molecular profiling of clear-cell renal cell carcinoma and prediction of response to targeted therapies against the vascular endothelial growth factor receptor, immune checkpoint inhibitors and mTOR inhibitors in the metastatic setting.From1 Oct 2016 → 30 Sep 2020Funding: FWO fellowships, Nonprofit institution or equivalents
Publications
11 - 20 of 22
- Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors(2019)
Authors: Annelies Verbiest, Annouschka Laenen, Patrick Schöffski, Maarten Albersen, Agnieszka Wozniak, Benoit Beuselinck
Pages: E981 - E994 - ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinib(2019)
Authors: Diether Lambrechts, Annelies Verbiest, Evelyne Lerut, Brigitte Decallonne, Patrick Schöffski, Oliver Bechter, Benoit Beuselinck
Pages: 180 - 188 - Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies(2019)
Authors: Annelies Verbiest, Kevin Punie, Oliver Bechter, Hans Wildiers, Evelyne Lerut, Herlinde Dumez, Brigitte Decallonne, Paul Clement, Dirk Vanderschueren, Maarten Albersen, et al.
Pages: 169 - 179 - Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib(2019)
Authors: Maxime Vanmechelen, Diether Lambrechts, Annelies Verbiest, Patrick Schöffski, Herlinde Dumez, Evelyne Lerut, Maarten Albersen, Benoit Beuselinck
Pages: E235 - E246 - Tumor molecular characteristics in patients (pts) with international metastatic renal cell carcinoma database consortium (IMDC) good (G) and intermediate/poor (I/P) risk.(2018)
Authors: Benoit Beuselinck, Annelies Verbiest, G Couchy, S Job, A de Reynies, S Caruso, V Verkarre, N Rioux-Leclercq, Patrick Schöffski, Y Vano, et al.
Pages: viii306 - viii307 - Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy(2018)
Authors: Annelies Verbiest, Evelyne Lerut, Raymond Oyen, Lorenzo Tosco, Steven Joniau, Hendrik Van Poppel, Dirk Van Raemdonck, Agnieszka Wozniak, Benoit Beuselinck
Pages: 474 - 480 - Polymorphisms in the Von Hippel-Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors(2018)
Authors: Annelies Verbiest, Diether Lambrechts, Agnieszka Wozniak, Evelyne Lerut, Benoit Beuselinck
Pages: 266 - 273 - Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic Setting(2018)
Authors: Annelies Verbiest, Evelyne Lerut, Raymond Oyen, Agnieszka Wozniak, Steven Joniau, Hendrik Van Poppel, Benoit Beuselinck
Pages: e605 - e612 - Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma(2018)
Authors: Benoit Beuselinck, Annelies Verbiest, Maarten Albersen, Evelyne Lerut, Patrick Schöffski
Pages: 498 - 508 - Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors(2018)
Authors: Tom van Cann, Annelies Verbiest, Paul Clement, Oliver Bechter, Ludo Willems, Isabel Spriet, Constantinus Politis, Joseph Schoenaers, Herlinde Dumez, Patrick Neven, et al.
Pages: 869 - 878